Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Head & Neck 3Endocrine 3

Conditions

Head and Neck Neoplasms 1870Squamous Cell Carcinoma of Head and Neck 1109Nasopharyngeal Carcinoma 535Thyroid Neoplasms 519Mouth Neoplasms 347Oropharyngeal Neoplasms 292Laryngeal Neoplasms 197Carcinoma, Squamous Cell 188Neoplasms 187Breast Neoplasms 183Lung Neoplasms 182Nasopharyngeal Neoplasms 160Thyroid Nodule 154Salivary Gland Neoplasms 135Thyroid Cancer, Papillary 122Neoplasm Metastasis 113Carcinoma, Non-Small-Cell Lung 113Hypopharyngeal Neoplasms 111Melanoma 105Prostatic Neoplasms 99Esophageal Neoplasms 95Colorectal Neoplasms 90Thyroid Diseases 87Uterine Cervical Neoplasms 82Recurrence 81Pancreatic Neoplasms 79Ovarian Neoplasms 70Sarcoma 68Stomach Neoplasms 65Xerostomia 62

Interventions

cabozantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Differentiated Thyroid Cancer (DTC) × Head & Neck × Clear all
NCT07229859 2025-11-17

Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening

Ruijin Hospital

Completed
332 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer (DTC)

NCT06855680 2025-03-21

The EMIRATES Study

Royal Marsden NHS Foundation Trust

Recruiting
15 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer (DTC)

NCT02041260 2021-10-15

A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting

Thomas Jefferson University

Phase 2 Unknown
43 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer (DTC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡